LIGAND PHARMACEUTICALS INCORPORATED Senior Notes, Noncurrent
LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) had Senior Notes, Noncurrent of $1.13 billion as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation
us-gaap:SeniorLongTermNotes · last filed 2026-08-07
- 2026-06-30: Senior Notes, Noncurrent $1.13B.
- 2026-03-31: Senior Notes, Noncurrent $446.90M.
- 2025-12-31: Senior Notes, Noncurrent $446.19M.
- 2025-09-30: Senior Notes, Noncurrent $445.49M.
| Period end | Senior Notes, Noncurrent |
|---|---|
| 2026-06-30 | $1.13B 10-Q · filed 2026-08-07 |
| 2026-03-31 | $446.90M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $446.19M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $445.49M 10-Q · filed 2025-11-07 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-27 |